Skip to main content

MINI REVIEW article

Front. Physiol., 08 June 2015
Sec. Integrative Physiology

Antenatal maternal hypoxia: criterion for fetal growth restriction in rodents

\r\nEeun Amy JangEeun Amy Jang1Lawrence D. Longo,Lawrence D. Longo1,2Ravi Goyal,*Ravi Goyal1,2*
  • 1Department of Basic Sciences, Center for Perinatal Biology, School of Medicine, Loma Linda University, Loma Linda, CA, USA
  • 2Epigenuity LLC, Loma Linda, CA, USA

Rodents are a useful model for life science research. Accumulating evidence suggests that the offspring of mice and rats suffer from similar disorders as humans when exposed to hypoxia during pregnancy. Importantly, with antenatal hypoxic exposure, human neonates demonstrate low birth weight or growth restriction. Similarly, with antenatal hypoxic exposure rodents also demonstrate the fetal growth restriction (FGR). Surprisingly, there is no consensus on the minimum duration or degree of hypoxic exposure required to cause FGR in rodents. Thus, we have reviewed the available literature in an attempt to answer these questions. Based on studies in rats, birth weight reduction of 31% corresponded to 10th percentile reduction in birth weight curve. With the similar criterion (10th percentile), in mice 3 days or more and in rats 7 days or more of 14% or lower hypoxia administration was required to produce statistically significant FGR.

Introduction

Antenatal stressors during pregnancy can lead to fetal diseases as well as the programing of disorders that occur in adulthood (Barker, 2002; Goyal and Longo, 2013; Goyal et al., 2013). Hypoxic stress in pregnancy is common and occurs in various scenarios such as at high altitude, maternal smoking, congestive heart failure, heart valvular diseases, pulmonary diseases, acute/chronic respiratory tract infections, anemia, preeclampsia, placental insufficiency, and others. When a fetus experiences hypoxic stress it redistributes its cardiac output to preferentially perfuse the heart and brain at the expense of other organs (Peeters et al., 1979; Kitanaka et al., 1989; Longo et al., 1993). This relative hypoxia can lead to various disruptions in normal fetal development and eventually to disorders in postnatal life. Antenatal maternal hypoxia has been shown to cause altered cardiac growth and neonatal vascular function, permanent neurological deficits, pulmonary arterial dysfunction, atherosclerosis, and fetal growth restriction (FGR) (McCullough et al., 1977; Unger et al., 1988).

The birth weight of an infant is an important factor to predict its chances of survival, healthy growth, and development. According to the Center for Disease Control (www.cdc.gov) low birth weight (LBW) has been defined as a birth weight of less than 2500 g. LBW could be a result of genetic background without any obvious factor inducing it. In such cases, the LBW infant is referred to as small for gestational age (SGA). However, placental, fetal, or maternal factors may be responsible for LBW. In such cases, in which the fetus is unable achieve its full genetic potential as a consequence of some known factor is diagnosed as FGR. FGR is one of the major complications of antenatal hypoxic exposure in humans, and defined as fetal weight below the 10th percentile of the population for its gestational age resulting from a pathological cause. Of note, FGR affects 7–10% of pregnancies or about 20.5 million infants each year (de Onis et al., 1998; Reece, 2008). FGR increases not only neonatal mortality and morbidity but the risk of diseases during adulthood as well (Hanson and Gluckman, 2008). Neonatal complications of FGR include: aspiration of meconium, neonatal hypoxia, hypoglycemia, and neonatal ischemic encephalopathy. The long-term sequelae during adulthood include lower IQ, increased risk of hypertension, metabolic syndrome, and cardiovascular diseases. The increased risk of diseases in adulthood aligns well with the developmental origins of adult health and disease (DOHaD) hypothesis. Considerable evidence demonstrates a correlation between LBW and subsequent development of cardiovascular diseases (Barker, 1992; Eriksson et al., 2002, 2007). Our previous studies have confirmed that LBW in mice may cause dysregulation of glucose metabolism as well as hypertension in later life with dysregulation of the renin-angiotensin system (Goyal and Longo, 2013; Goyal et al., 2013).

Because of these implications and far-reaching consequences, there is considerable interest in using rodent models in the study of hypoxia-induced FGR. While rodents have been used for more than two decades for this purpose, to date we know of no systematic review to determine what concentrations, durations, and methods of administering hypoxia lead to FGR. Thus, the aim of this report is to determine the parameters of hypoxia that induce FGR in the rodent model. The major questions we asked were: What duration of hypoxia administered will lead to FGR offspring in rodents? When is the optimal time during gestation to administer hypoxia to cause FGR in rodent offspring? What concentration of oxygen administered will lead to FGR offspring in rodents? What is the effect of hypoxia on litter size and maternal food intake? What standards should investigators use to define FGR in the rodent offspring?

Methods

We conducted a PubMed search using combinations of different study terms such as FGR, fetal growth retardation, intra-uterine growth restriction, intra-uterine growth retardation, LBW, small for gestation age as the first keyword, mice or rats as a second keyword, and hypoxia as a third keyword. Our search included all studies indexed in Pubmed. From these searches, we identified six studies in the mouse or 22 in the rats that were relevant to antenatal maternal hypoxia-induced FGR. Multiple studies from the same investigators using the same hypoxia-induced FGR model were included if they reported different parameters or difference in % of weight reduction. A host of studies deemed irrelevant to the current research questions were excluded. These included studies using methods such as uterine artery ligation, uterine carunculectomy, and studies examining other hypoxia-induced variables such as birth defects, gene expression, and review articles. In two studies (Ravishankar et al., 2007; Dolinsky et al., 2011), pup birth weights were not reported and were excluded from analysis. Also, one of these studies administered both hypoxia and a nitric oxide inhibitor to the pregnant dam with a significant reduction in pups birth weight (Ravishankar et al., 2007). Another study that used hypoxia and uterine artery ligation to induce FGR was also excluded (Thordstein and Hedner, 1992).

Of further consideration, investigators reported their findings of FGR in a variety of manners. Some reported the average weights of both normoxic and hypoxic groups, with the standard deviation and p-value to indicate significance. Others reported a percentage difference in weight with p-value. To compare the results from all studies, whenever possible, we converted all results to weight difference in percentage.

Results and Discussion

What Duration of Hypoxia Administered Will Lead to FGR Offspring in Rodents?

Quite obviously, this question is complicated as being a function of both oxygen concentration and the duration of administration. In the case of the rat (Table 1), most studies administered hypoxia for 5–7 days during the last week of pregnancy. The longest duration of hypoxia administration was from day post conceptional (DPC) 7–21 (14 days) with 10% oxygen. This resulted in birth weight reduction by 16.9% (p < 0.01) (Wang et al., 2009). In comparison, the shortest duration of hypoxia to rat dams, was the exposure to 10% oxygen for 3 h on DPC 20 without development of FGR (Huang et al., 2004). Another study administered 9.5–10.5% oxygen for either 3 h, 1 day, or 11 days to three different groups of rats before sacrificing the mother on DPC 20 (Huang et al., 2004). Fetal weight in the 3 h and 1 day groups showed no significant change from normoxic controls. In contrast, following 11 days exposure, fetal weight was reduced by 31.3% (P < 0.05). Both litter size and placental weight were also significantly reduced. Furthermore, in a recent study, 12–14% of oxygen for 7 days (from gestational age 14–21 days) lead to 31% (P < 0.050) reduction in pups birth weight (Deng et al., 2015). The shortest duration of hypoxia that resulted in significantly reduced weight in the rat offspring was 3 days. Two studies demonstrated a 20% reduction in fetal weight and 11% reduction in placental weight (P < 0.003) with 12 and 14% oxygen administration on DPC 18–21 (Thaete et al., 1997, 2004). Thus, it appears that a minimum duration of 3 days of hypoxic exposure is necessary for inducing FGR.

TABLE 1
www.frontiersin.org

Table 1. Studies examining hypoxia-induced growth restriction in rats.

In contrast to the rat, the mouse had less variation in duration of hypoxia (Table 2). In these studies, the longest hypoxic duration administered was 8 days (Rueda-Clausen et al., 2014), while the shortest was 12 h. In a recent study, 8 days exposure of 10.5% hypoxia caused 36% decrease in pups birth weight as compared to normoxic controls (Rueda-Clausen et al., 2014). Moreover, increased neonatal mortality was also reported in this study without any decrease in litter size. Two groups, Gortner et al. (2005) and Tomlinson et al. (Tracy et al., 2010), administered 3 days of hypoxia in the last week of pregnancy, at 10 and 12% oxygen, respectively. Gortner et al. reported a 28.9% decrease in pups weight, while Tomlinson only mentioned a statistically significant decrease in pup weight with P < 0.05. Our studies with 10.5% oxygen for 48 h between DPC 15.5–17.5 demonstrated no significant change in pups birth weight (Gheorghe et al., 2010; Goyal et al., 2011a,b). In another study, hypoxia was given for 12 or 24 h on DPC 11.5–12.5, at 8% oxygen concentration (Ream et al., 2008). Importantly 8% oxygen is a comparatively more severe hypoxic exposure, than that of other studies, which used 10–12% oxygen. Additionally, this study is unique from other reports in that it used a low oxygen concentration and administered hypoxia to the pregnant mouse during the second week post coitum. While the 12-h hypoxia group showed no significant difference in fetal weight from the controls, the 24-h group showed a 26% reduction in fetal weight compared to the control group. This is in contrast to our findings that 48 h of hypoxia showed no significant change in birth weight. However, in the study by Ream et al., the investigators used 8% hypoxia, and in our studies we used 10.5% hypoxia. Also, in other studies we observed that pre-conceptional 10% hypoxia for 4 days failed to induce FGR in mice (unpublished observation). Thus, based on the studies on rodents, we conclude that 3 days of moderate hypoxia in the 10–14% range results in significant FGR. Also, increasing the severity to 8% for at least 24 h can produce a significant decrease in birth weight. Notably, 8% oxygen in the rabbit is a critical level associated with fetal death (Power et al., 1977).

TABLE 2
www.frontiersin.org

Table 2. Studies examining hypoxia-induced growth restriction in mice.

What is the Effect of Hypoxia on Litter Size and Maternal Food Intake?

Most of the studies did not report the effect of hypoxia on litter size. A study which administered hypoxia for 11 days reported reduced litter size, but failed to mention the exact number (Huang et al., 2004). Another study with severe hypoxia exposure of 9.5% for 12 days demonstrated significant reduction in litter size (Van Geijn et al., 1980). Both these studies administered the hypoxic insult for more than half of the gestation period. However, studies for 6 days of hypoxia of 12% oxygen showed no significant difference in the litter size in same rat strain (Rueda-Clausen et al., 2009, 2011; Morton et al., 2010). Similarly, 5 days hypoxia (E15–20) of 10% oxygen did not lead to significant change in litter size (Lueder et al., 1995). In the same study no effect of hypoxia was reported on the maternal food intake. Similarly, no effect of hypoxic exposure on maternal food intake was reported in response to 12 days hypoxic exposure (10% from E9 to E21) (Vosatka et al., 1998). In contrast, few other groups (Tables 1, 2) have reported reduced maternal food intake in response to hypoxia (Huang et al., 2004; Williams et al., 2005a,b; Ream et al., 2008; Tracy et al., 2010; Reyes et al., 2015). However, in other studies from the same group there is no mention of changes in maternal food intake in response to hypoxia exposure (Rueda-Clausen et al., 2009, 2011, 2014; Morton et al., 2010). Therefore, further investigations are needed to clarify how hypoxia-influences litter size and maternal food intake.

When is the Optimal Time during Gestation to Administer Hypoxia to Cause FGR in Rodent Offspring?

In reviewing these reports, we noted that most studies examined the effects of hypoxia during the last week of pregnancy. Only a handful of studies examined the effects of hypoxia during the second week, and no studies examined these effects during the first week. The question is, to what extent does the hypoxic exposure during different time periods of gestation affect offspring birth weight?

In the mouse three of the six studies administered hypoxia in the third week of pregnancy, while three studies administered hypoxia in the second week. The three studies administering hypoxia in the last week reported FGR with a statistically significant difference in the pups' birth weight (Gortner et al., 2005; Tracy et al., 2010; Rueda-Clausen et al., 2014). Gortner et al. reported a ~29% reduction of birth weight in the hypoxic group (Ream et al., 2008). In comparison, administering hypoxia in the second week resulted in a 26% reduction of birth weight.

In the rats, 18 of the 22 studies administered hypoxia in the last week of pregnancy, while 4 of the 22 studies administered hypoxia in the second and third weeks (Table 1). Again, none of the studies administered hypoxia in the first week. These reports suggest that irrespective of second or last week, the development of FGR is more dependent upon both duration and degree of the hypoxic insult. Importantly, in humans and most other species, most fetal growth occurs during the last trimester of pregnancy, and some would argue that this is the most critical period to examine the effect of antenatal maternal hypoxia on newborn birth weight.

What Concentration of Oxygen Administered Will Lead to FGR Offspring In Rodents?

To answer this question, we looked at percentage of oxygen administered in each study and the effect produced in pup weight. The percentage of oxygen administered varied from 8 to 12% in the mice studies and 9.5–14% in the rat studies. Significant reductions in pup weight were reported at each of these oxygen concentrations. Concurrently, non-significant reductions in pup weight were reported at many levels of oxygen as well, including the two ends of the spectrum at 8 and 14% oxygen (Huang et al., 2004; Bahtiyar et al., 2007; Tracy et al., 2010; Goyal et al., 2011a,b). This variability was dependent on the duration of hypoxia given in each study. While, oxygen levels below 11% produced significant reduction in pup weight (Van Geijn et al., 1980; Lueder et al., 1995; Vosatka et al., 1998; Huang et al., 2004; Thaete et al., 2004; Gortner et al., 2005; Bahtiyar et al., 2007; Jakoubek et al., 2008; Ream et al., 2008; Wang et al., 2009), two studies that administered hypoxia (8 to 9.5% oxygen levels) for 1 day or less did not achieve significant FGR (Huang et al., 2004; Ream et al., 2008). In rats, Huang et al. administered 9.5–10.5% oxygen for 3 h as well as for a day and reported no significant reduction in pup birth weight. Ream et al. administered 8% oxygen for 12 h to mice and reported pup weight reduction that was not significant (Ream et al., 2008). Thus, the duration of hypoxic exposure appears to be a major factor in determining the development of FGR than the degree of hypoxia per se.

What Standards Should Investigators Use to Define FGR in the Offspring?

Lastly, we examined the criteria investigators used to determine a positive finding of FGR in these studies. Each investigator used a statistically significant difference (P < 0.05), compared to normoxic control to label the pups as FGR. In more than 100 control litters, a group of investigators further determined how this statistically significant weight translated into percentile, and defined FGR as birth weight below the 15th percentile of sex-matched controls (Rueda-Clausen et al., 2009, 2011; Morton et al., 2010). In a recent study in rats, 31% reduction in birth weight was reported for 10th percentile of birth weight for gestational age reference curve (Deng et al., 2015). In this study, FGR incidence was 54.4% in the hypoxic group as compared to 5.6% FGR in the normoxic group.

As noted above, in human neonates, the weight criterion for FGR is below the 10th percentile of the population at the respective gestational age. Thus, a statistically significant reduction in weight does not translate directly to a weight below the 10th percentile of the population. The average birth weight of a near-term human newborn is about 3200 g. The weight criterion for FGR is below 2500 g. This translates into a minimum of 22% reduction in weight, at which point the perinatal mortality rate is 5–30 times greater than that of a newborn of normal weight. At 1500 g, or a 53% reduction in weight, the perinatal mortality rate increases to 70–100 times greater. In this review, we identified only two studies in mice (Ream et al., 2008; Rueda-Clausen et al., 2014) and one study in the rat (Tapanainen et al., 1994), which mentioned significant increase in newborn pups mortality following maternal hypoxia. All other studies did not report neonatal mortality in response to maternal hypoxia exposure. However, further investigations are needed to evaluate the relationship of rodents pups birth weight and neonatal mortality.

Conclusion and Perspective

We conclude from this analysis that 14% or lower level of oxygen for 3 days or more is sufficient to produce FGR in rodents. Also, the second half of pregnancy (chiefly the third week) is the time frame most studied for hypoxic insult, but earlier exposure may also lead to FGR. Importantly, we propose that in rodents, at least 22% or more reduction in pups birth weight should be considered as FGR.

Conflict of Interest Statement

The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.

References

Bahtiyar, M. O., Buhimschi, C., Ravishankar, V., Copel, J., Norwitz, E., Julien, S., et al. (2007). Contrasting effects of chronic hypoxia and nitric oxide synthase inhibition on circulating angiogenic factors in a rat model of growth restriction. Am. J. Obstet. Gynecol. 196, 72.e1–72.e6. doi: 10.1016/j.ajog.2006.07.048

CrossRef Full Text | Google Scholar

Barker, D. J. (1992). Fetal growth and adult disease. Br. J. Obstet. Gynaecol. 99, 275–276. doi: 10.1111/j.1471-0528.1992.tb13719.x

PubMed Abstract | CrossRef Full Text | Google Scholar

Barker, D. J. (2002). Fetal programming of coronary heart disease. Trends Endocrinol. Metab. 13, 364–368. doi: 10.1016/s1043-2760(02)00689-6

PubMed Abstract | CrossRef Full Text | Google Scholar

de Onis, M., Blossner, M., and Villar, J. (1998). Levels and patterns of intrauterine growth retardation in developing countries. Eur. J. Clin. Nutr. 52(Suppl. 1), S5–S15.

PubMed Abstract | Google Scholar

Deng, F. T., Ouyang, W. X., Ge, L. F., Zhang, L., and Chai, X. Q. (2015). Expression of lung surfactant proteins SP-B and SP-C and their modulating factors in fetal lung of FGR rats. J. Huazhong Univ. Sci. Technol. Med. Sci. 35, 122–128. doi: 10.1007/s11596-015-1400-y

PubMed Abstract | CrossRef Full Text | Google Scholar

Dolinsky, V. W., Rueda-Clausen, C. F., Morton, J. S., Davidge, S. T., and Dyck, J. R. B. (2011). Continued postnatal administration of resveratrol prevents diet-induced metabolic syndrome in rat offspring born growth restricted. Diabetes 60, 2274–2284. doi: 10.2337/db11-0374

PubMed Abstract | CrossRef Full Text | Google Scholar

Eriksson, J. G., Forsen, T., Tuomilehto, J., Jaddoe, V. W., Osmond, C., and Barker, D. J. (2002). Effects of size at birth and childhood growth on the insulin resistance syndrome in elderly individuals. Diabetologia 45, 342–348. doi: 10.1007/s00125-001-0757-6

PubMed Abstract | CrossRef Full Text | Google Scholar

Eriksson, J. G., Forsen, T. J., Kajantie, E., Osmond, C., and Barker, D. J. (2007). Childhood growth and hypertension in later life. Hypertension 49, 1415–1421. doi: 10.1161/HYPERTENSIONAHA.106.085597

PubMed Abstract | CrossRef Full Text | Google Scholar

Gheorghe, C. P., Goyal, R., Mittal, A., and Longo, L. D. (2010). Gene expression in the placenta: maternal stress and epigenetic responses. Int. J. Dev. Biol. 54, 507–523. doi: 10.1387/ijdb.082770cg

PubMed Abstract | CrossRef Full Text | Google Scholar

Gortner, L., Hilgendorff, A., Bähner, T., Ebsen, M., Reiss, I., and Rudloff, S. (2005). Hypoxia-induced intrauterine growth retardation: effects on pulmonary development and surfactant protein transcription. Biol. Neonate 88, 129–135. doi: 10.1159/000085895

PubMed Abstract | CrossRef Full Text | Google Scholar

Goyal, R., Leitzke, A., Goyal, D., Gheorghe, C. P., and Longo, L. D. (2011a). Antenatal maternal hypoxic stress: adaptations in fetal lung Renin-Angiotensin system. Reprod. Sci. 18, 180–189. doi: 10.1177/1933719110385134

PubMed Abstract | CrossRef Full Text | Google Scholar

Goyal, R., Lister, R., Leitzke, A., Goyal, D., Gheorghe, C. P., and Longo, L. D. (2011b). Antenatal maternal hypoxic stress: adaptations of the placental renin-angiotensin system in the mouse. Placenta 32, 134–139. doi: 10.1016/j.placenta.2010.11.004

PubMed Abstract | CrossRef Full Text | Google Scholar

Goyal, R., and Longo, L. D. (2013). Maternal protein deprivation: sexually dimorphic programming of hypertension in the mouse. Hypertens Res. 36, 29–35. doi: 10.1038/hr.2012.129

PubMed Abstract | CrossRef Full Text | Google Scholar

Goyal, R., Wong, C., Van Wickle, J., and Longo, L. D. (2013). Antenatal maternal protein deprivation: sexually dimorphic programming of the pancreatic renin-angiotensin system. J. Renin Angiotensin Aldosterone Syst. 14, 137–145. doi: 10.1177/1470320312456329

PubMed Abstract | CrossRef Full Text | Google Scholar

Hanson, M. A., and Gluckman, P. D. (2008). Developmental origins of health and disease: new insights. Basic Clin. Pharmacol. Toxicol. 102, 90–93. doi: 10.1111/j.1742-7843.2007.00186.x

PubMed Abstract | CrossRef Full Text | Google Scholar

Hemmings, D. G., Williams, S. J., and Davidge, S. T. (2005). Increased myogenic tone in 7-month-old adult male but not female offspring from rat dams exposed to hypoxia during pregnancy. Am. J. Physiol. Heart. Circ. Physiol. 289, H674–H682.

PubMed Abstract | Google Scholar

Huang, S. T. J., Vo, K. C. T., Lyell, D. J., Faessen, G. H., Tulac, S., Tibshirani, R., et al. (2004). Developmental response to hypoxia. FASEB J. 18, 1348–1365. doi: 10.1096/fj.03-1377com

PubMed Abstract | CrossRef Full Text | Google Scholar

Jakoubek, V., Bibova, J., Herget, J., and Hampl, V. (2008). Chronic hypoxia increases fetoplacental vascular resistance and vasoconstrictor reactivity in the rat. Am. J. Physiol. Heart Circ. Physiol. 294, H1638–H1644. doi: 10.1152/ajpheart.01120.2007

PubMed Abstract | CrossRef Full Text | Google Scholar

Kitanaka, T., Alonso, J. G., Gilbert, R. D., Siu, B. L., Clemons, G. K., and Longo, L. D. (1989). Fetal responses to long-term hypoxemia in sheep. Am. J. Physiol. 256, R1348–R1354.

PubMed Abstract | Google Scholar

Longo, L. D., Hull, A. D., Long, D. M., and Pearce, W. J. (1993). Cerebrovascular adaptations to high-altitude hypoxemia in fetal and adult sheep. Am. J. Physiol. 264, R65–R72.

PubMed Abstract | Google Scholar

Lueder, F. L., Kim, S.-B., Buroker, C. A., Bangalore, S. A., and Ogata, E. S. (1995). Chronic maternal hypoxia retards fetal growth and increases glucose utilization of select fetal tissues in the rat. Metabolism 44, 532–537. doi: 10.1016/0026-0495(95)90063-2

PubMed Abstract | CrossRef Full Text | Google Scholar

McCullough, R. E., Reeves, J. T., and Liljegren, R. L. (1977). Fetal growth retardation and increased infant mortility at high altitude. Obstet. Gynecol. Surv. 32, 596–598. doi: 10.1097/00006254-197709000-00012

PubMed Abstract | CrossRef Full Text | Google Scholar

Morton, J. S., Rueda-Clausen, C. F., and Davidge, S. T. (2010). Mechanisms of endothelium-dependent vasodilation in male and female, young and aged offspring born growth restricted. Am. J. Physiol. Regul. Integr. Comp. Physiol. 298, R930–R938. doi: 10.1152/ajpregu.00641.2009

PubMed Abstract | CrossRef Full Text | Google Scholar

Morton, J. S., Rueda-Clausen, C. F., and Davidge, S. T. (2011). Flow-mediated vasodilation is impaired in adult rat offspring exposed to prenatal hypoxia. J. Appl. Physiol. 110, 1073–1082. doi: 10.1152/japplphysiol.01174.2010

PubMed Abstract | CrossRef Full Text | Google Scholar

Peeters, L. L., Sheldon, R. E., Jones, M. D., Makowski, E. L., and Meschia, G. (1979). Blood flow to fetal organs as a function of arterial oxygen content. Am. J. Obstet. Gynecol. 135, 637–646.

PubMed Abstract | Google Scholar

Power, G. G., Bennett, T. R., and Longo, L. D. (1977). Survival in the fetal rabbit exposed to intermittent hypoxia. Am. J. Obstet. Gynecol. 127, 428–433.

PubMed Abstract | Google Scholar

Ravishankar, V., Buhimschi, C. S., Booth, C. J., Bhandari, V., Norwitz, E., Copel, J., et al. (2007). Fetal nucleated red blood cells in a rat model of intrauterine growth restriction induced by hypoxia and nitric oxide synthase inhibition. Am. J. Obstet. Gynecol. 196, 482.e1–482.e8. doi: 10.1016/j.ajog.2006.12.020

PubMed Abstract | CrossRef Full Text | Google Scholar

Ream, M., Ray, A. M., Chandra, R., and Chikaraishi, D. M. (2008). Early fetal hypoxia leads to growth restriction and myocardial thinning. Am. J. Physiol. Regul. Integr. Comp. Physiol. 295, R583–R595. doi: 10.1152/ajpregu.00771.2007

PubMed Abstract | CrossRef Full Text | Google Scholar

Reece, E. A. (2008). Perspectives on obesity, pregnancy and birth outcomes in the United States: the scope of the problem. Am. J. Obstet. Gynecol. 198, 23–27. doi: 10.1016/j.ajog.2007.06.076

PubMed Abstract | CrossRef Full Text | Google Scholar

Reyes, L. M., Morton, J. S., Kirschenman, R., DeLorey, D. S., and Davidge, S. T. (2015). Vascular effects of aerobic exercise training in rat adult offspring exposed to hypoxia-induced intrauterine growth restriction. J. Physiol. 593, 1913–1929. doi: 10.1113/jphysiol.2014.288449

PubMed Abstract | CrossRef Full Text | Google Scholar

Rueda-Clausen, C. F., Morton, J. S., and Davidge, S. T. (2009). Effects of hypoxia-induced intrauterine growth restriction on cardiopulmonary structure and function during adulthood. Cardiovasc. Res. 81, 713–722. doi: 10.1093/cvr/cvn341

PubMed Abstract | CrossRef Full Text | Google Scholar

Rueda-Clausen, C. F., Morton, J. S., Lopaschuk, G. D., and Davidge, S. T. (2011). Long-term effects of intrauterine growth restriction on cardiac metabolism and susceptibility to ischaemia/reperfusion. Cardiovasc. Res. 90, 285–294. doi: 10.1093/cvr/cvq363

PubMed Abstract | CrossRef Full Text | Google Scholar

Rueda-Clausen, C. F., Stanley, J. L., Thambiraj, D. F., Poudel, R., Davidge, S. T., and Baker, P. N. (2014). Effect of prenatal hypoxia in transgenic mouse models of preeclampsia and fetal growth restriction. Reprod. Sci. 21, 492–502. doi: 10.1177/1933719113503401

PubMed Abstract | CrossRef Full Text | Google Scholar

Tapanainen, P. J., Bang, P., Wilson, K., Unterman, T. G., Vreman, H. J., and Rosenfeld, R. G. (1994). Maternal hypoxia as a model for intrauterine growth retardation: effects on insulin-like growth factors and their binding proteins. Pediatr. Res. 36, 152–158. doi: 10.1203/00006450-199408000-00004

PubMed Abstract | CrossRef Full Text | Google Scholar

Thaete, L. G., Dewey, E. R., and Neerhof, M. G. (2004). Endothelin and the regulation of uterine and placental perfusion in hypoxia-induced fetal growth restriction. J. Soc. Gynecol. Investig. 11, 16–21. doi: 10.1016/j.jsgi.2003.07.001

PubMed Abstract | CrossRef Full Text | Google Scholar

Thaete, L. G., Neerhof, M. G., and Caplan, M. S. (1997). Endothelin receptor A antagonism prevents hypoxia-induced intrauterine growth restriction in the rat. Am. J. Obstet. Gynecol. 176, 73–76. doi: 10.1016/S0002-9378(97)80014-2

PubMed Abstract | CrossRef Full Text | Google Scholar

Thordstein, M., and Hedner, T. (1992). Cerebral and adrenal monoamine metabolism in the growth-retarded rat fetus under normoxia and hypoxia. Pediatr. Res. 31, 131–137. doi: 10.1203/00006450-199202000-00008

PubMed Abstract | CrossRef Full Text | Google Scholar

Tracy, M. T., Garbow, J. R., Anderson, J. R., Engelbach, J. A., Nelson, D. M., and Sadovsky, Y. (2010). Magnetic resonance imaging of hypoxic injury to the murine placenta. Am. J. Physiol. Regul. Integr. Comp. Physiol. 298, R312. doi: 10.1152/ajpregu.00425.2009

PubMed Abstract | CrossRef Full Text | Google Scholar

Unger, C., Weiser, J. K., McCullough, R. E., Keefer, S., and Moore, L. G. (1988). Altitude, low birth weight, and infant mortality in Colorado. JAMA 259, 3427–3432. doi: 10.1001/jama.1988.03720230037027

PubMed Abstract | CrossRef Full Text | Google Scholar

Van Geijn, H. P., Kaylor, W. M., Nicola, K. R., and Zuspan, F. P. (1980). Induction of severe intrauterine growth retardation in the Sprague-Dawley rat. Am. J. Obstet. Gynecol. 137, 43–47.

PubMed Abstract | Google Scholar

Vosatka, R. J., Hassoun, P. M., and Harvey-Wilkes, K. B. (1998). Dietary L-arginine prevents fetal growth restriction in rats. Am. J. Obstet. Gynecol. 178, 242–246. doi: 10.1016/S0002-9378(98)80007-0

PubMed Abstract | CrossRef Full Text | Google Scholar

Wang, Z., Huang, Z., Lu, G., Lin, L., and Ferrari, M. (2009). Hypoxia during pregnancy in rats leads to early morphological changes of atherosclerosis in adult offspring. Am. J. Physiol. Heart Circ. Physiol. 296, H1321–H1328. doi: 10.1152/ajpheart.00440.2008

PubMed Abstract | CrossRef Full Text | Google Scholar

Williams, S. J., Campbell, M. E., McMillen, I. C., and Davidge, S. T. (2005a). Differential effects of maternal hypoxia or nutrient restriction on carotid and femoral vascular function in neonatal rats. Am. J. Physiol. Regul. Integr. Comp. Physiol. 288, R360–R367. doi: 10.1152/ajpregu.00178.2004

PubMed Abstract | CrossRef Full Text | Google Scholar

Williams, S. J., Hemmings, D. G., Mitchell, J. M., McMillen, I. C., and Davidge, S. T. (2005b). Effects of maternal hypoxia or nutrient restriction during pregnancy on endothelial function in adult male rat offspring. J. Physiol. 565, 125–135. doi: 10.1113/jphysiol.2005.084889

PubMed Abstract | CrossRef Full Text | Google Scholar

Xu, Y., Williams, S. J., O'Brien, D., and Davidge, S. T. (2006). Hypoxia or nutrient restriction during pregnancy in rats leads to progressive cardiac remodeling and impairs postischemic recovery in adult male offspring. FASEB J. 20, 1251–1253.

PubMed Abstract | Google Scholar

Keywords: intra uterine growth restriction, intra uterine growth retardation (IUGR), small for gestational age, low birth weight, maternal stress, developmental origins of adult health and diseases, fetal origins hypothesis, fetal programming

Citation: Jang EA, Longo LD and Goyal R (2015) Antenatal maternal hypoxia: criterion for fetal growth restriction in rodents. Front. Physiol. 6:176. doi: 10.3389/fphys.2015.00176

Received: 17 April 2015; Accepted: 25 May 2015;
Published: 08 June 2015.

Edited by:

Kate Denton, Monash University, Australia

Reviewed by:

Jacqueline Kathleen Phillips, Macquarie University, Australia
Dragomir N. Serban, Grigore T. Popa University of Medicine and Pharmacy, Romania

Copyright © 2015 Jang, Longo and Goyal. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) or licensor are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.

*Correspondence: Ravi Goyal, Department of Basic Sciences, Center for Perinatal Biology, School of Medicine, Loma Linda University, 11234 Anderson Street, Loma Linda, CA 92350, USA, rgoyal@llu.edu

Disclaimer: All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.